专利检索 ap:("Eli Lilly AND Company") AND inv:"WETTERAU II, John Rowley" 第 1 页

1.

发明授权
CONDENSED THIOPHENE DERIVATIVES USEFUL AS NAPI-IIB INHIBITORS 有权

公开(公告)号：EP3497091B1

公开(公告)日：2020-10-07

申请号：EP17754914.4

申请日：2017-08-08

申请人： Eli Lilly and Company

发明人： COATES, David Andrew , FALES, Kevin Robert , PETERSON, Jeffrey Alan , SCHKERYANTZ, Jeffrey Michael , SHEN, Quanrong , VALLI, Matthew John , WETTERAU II, John Rowley , WODKA, Dariusz Stanislaw , XU, Yangping

IPC分类号： C07D333/66 , A61K31/381 , A61K31/496 , A61K31/4995 , C07D471/10 , A61P9/00 , A61P13/12

2.

发明公开
CONDENSED THIOPHENE DERIVATIVES USEFUL AS NAPI-IIB INHIBITORS 审中-公开

公开(公告)号：EP3497091A1

公开(公告)日：2019-06-19

申请号：EP17754914.4

申请日：2017-08-08

申请人： Eli Lilly and Company

发明人： COATES, David Andrew , FALES, Kevin Robert , PETERSON, Jeffrey Alan , SCHKERYANTZ, Jeffrey Michael , SHEN, Quanrong , VALLI, Matthew John , WETTERAU II, John Rowley , WODKA, Dariusz Stanislaw , XU, Yangping

IPC分类号： C07D333/66 , A61K31/381 , A61K31/496 , A61K31/4995 , C07D471/10 , A61P9/00 , A61P13/12

摘要： The invention provides compounds of the formula: (A), pharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat hyperphosphatemia, chronic kidney disease, and/or the cardiovascular diease associated with chronic kidney disease.